Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition

Pioglitazone (PIO) is an insulin-sensitizing antidiabetic drug, which normalizes glucose and lipid metabolism but may provoke heart and liver failure and chronic kidney diseases. Both therapeutic and adverse effects of PIO can be accomplished through mitochondrial targets. Here, we explored the capa...

Full description

Bibliographic Details
Main Authors: Ekaterina S. Kharechkina, Anna B. Nikiforova, Konstantin N. Belosludtsev, Tatyana I. Rokitskaya, Yuri N. Antonenko, Alexey G. Kruglov
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/10/1045
_version_ 1827678791927857152
author Ekaterina S. Kharechkina
Anna B. Nikiforova
Konstantin N. Belosludtsev
Tatyana I. Rokitskaya
Yuri N. Antonenko
Alexey G. Kruglov
author_facet Ekaterina S. Kharechkina
Anna B. Nikiforova
Konstantin N. Belosludtsev
Tatyana I. Rokitskaya
Yuri N. Antonenko
Alexey G. Kruglov
author_sort Ekaterina S. Kharechkina
collection DOAJ
description Pioglitazone (PIO) is an insulin-sensitizing antidiabetic drug, which normalizes glucose and lipid metabolism but may provoke heart and liver failure and chronic kidney diseases. Both therapeutic and adverse effects of PIO can be accomplished through mitochondrial targets. Here, we explored the capability of PIO to modulate the mitochondrial membrane potential (ΔΨ<sub>m</sub>) and the permeability transition pore (mPTP) opening in different models in vitro. ΔΨ<sub>m</sub> was measured using tetraphenylphosphonium and the fluorescent dye rhodamine 123. The coupling of oxidative phosphorylation was estimated polarographically. The transport of ions and solutes across membranes was registered by potentiometric and spectral techniques. We found that PIO decreased ΔΨ<sub>m</sub> in isolated mitochondria and intact thymocytes and the efficiency of ADP phosphorylation, particularly after the addition of Ca<sup>2+</sup>. The presence of the cytosolic fraction mitigated mitochondrial depolarization but made it sustained. Carboxyatractyloside diminished the PIO-dependent depolarization. PIO activated proton transport in deenergized mitochondria but not in artificial phospholipid vesicles. PIO had no effect on K<sup>+</sup> and Ca<sup>2+</sup> inward transport but drastically decreased the mitochondrial Ca<sup>2+</sup>-retention capacity and protective effects of adenine nucleotides against mPTP opening. Thus, PIO is a mild, partly ATP/ADP-translocase-dependent, uncoupler and a modulator of ATP production and mPTP sensitivity to Ca<sup>2+</sup> and adenine nucleotides. These properties contribute to both therapeutic and adverse effects of PIO.
first_indexed 2024-03-10T06:16:54Z
format Article
id doaj.art-132070f6221b47b3a2a2edfb90a56b86
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T06:16:54Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-132070f6221b47b3a2a2edfb90a56b862023-11-22T19:36:38ZengMDPI AGPharmaceuticals1424-82472021-10-011410104510.3390/ph14101045Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability TransitionEkaterina S. Kharechkina0Anna B. Nikiforova1Konstantin N. Belosludtsev2Tatyana I. Rokitskaya3Yuri N. Antonenko4Alexey G. Kruglov5Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, RussiaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, RussiaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, RussiaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskaya 3, 142290 Pushchino, RussiaPioglitazone (PIO) is an insulin-sensitizing antidiabetic drug, which normalizes glucose and lipid metabolism but may provoke heart and liver failure and chronic kidney diseases. Both therapeutic and adverse effects of PIO can be accomplished through mitochondrial targets. Here, we explored the capability of PIO to modulate the mitochondrial membrane potential (ΔΨ<sub>m</sub>) and the permeability transition pore (mPTP) opening in different models in vitro. ΔΨ<sub>m</sub> was measured using tetraphenylphosphonium and the fluorescent dye rhodamine 123. The coupling of oxidative phosphorylation was estimated polarographically. The transport of ions and solutes across membranes was registered by potentiometric and spectral techniques. We found that PIO decreased ΔΨ<sub>m</sub> in isolated mitochondria and intact thymocytes and the efficiency of ADP phosphorylation, particularly after the addition of Ca<sup>2+</sup>. The presence of the cytosolic fraction mitigated mitochondrial depolarization but made it sustained. Carboxyatractyloside diminished the PIO-dependent depolarization. PIO activated proton transport in deenergized mitochondria but not in artificial phospholipid vesicles. PIO had no effect on K<sup>+</sup> and Ca<sup>2+</sup> inward transport but drastically decreased the mitochondrial Ca<sup>2+</sup>-retention capacity and protective effects of adenine nucleotides against mPTP opening. Thus, PIO is a mild, partly ATP/ADP-translocase-dependent, uncoupler and a modulator of ATP production and mPTP sensitivity to Ca<sup>2+</sup> and adenine nucleotides. These properties contribute to both therapeutic and adverse effects of PIO.https://www.mdpi.com/1424-8247/14/10/1045permeability transition poreunilamellar vesiclesadenine nucleotide translocaseuncoupling proteinATP production
spellingShingle Ekaterina S. Kharechkina
Anna B. Nikiforova
Konstantin N. Belosludtsev
Tatyana I. Rokitskaya
Yuri N. Antonenko
Alexey G. Kruglov
Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
Pharmaceuticals
permeability transition pore
unilamellar vesicles
adenine nucleotide translocase
uncoupling protein
ATP production
title Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
title_full Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
title_fullStr Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
title_full_unstemmed Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
title_short Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition
title_sort pioglitazone is a mild carrier dependent uncoupler of oxidative phosphorylation and a modulator of mitochondrial permeability transition
topic permeability transition pore
unilamellar vesicles
adenine nucleotide translocase
uncoupling protein
ATP production
url https://www.mdpi.com/1424-8247/14/10/1045
work_keys_str_mv AT ekaterinaskharechkina pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition
AT annabnikiforova pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition
AT konstantinnbelosludtsev pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition
AT tatyanairokitskaya pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition
AT yurinantonenko pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition
AT alexeygkruglov pioglitazoneisamildcarrierdependentuncouplerofoxidativephosphorylationandamodulatorofmitochondrialpermeabilitytransition